RECOMBINANT ADAMTS13 (rADAMTS13), RECOMBINANT ADAMTS13 (rADAMTS13)
TAK-755-3002
Phase 3 small_molecule active
Quick answer
RECOMBINANT ADAMTS13 (rADAMTS13), RECOMBINANT ADAMTS13 (rADAMTS13) for Congenital Thrombotic thrombocytopenic purpura (cTTP) is a Phase 3 program (small_molecule) at Baxalta Innovations GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Baxalta Innovations GmbH
- Indication
- Congenital Thrombotic thrombocytopenic purpura (cTTP)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active